← SynDRA
JNJ-39758979
SynDRA canonical compound SYN0037998 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HRH4 |
|---|
| Mechanism of action | histamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- histamine receptor antagonist
Cross-references
Synonyms
- JNJ 39758979
- (-)-
- JNJ39758979
- JNJ_39758979
- JNJ-39758979, (-)-
- jnj39758979
- 5RV7T5BNMG
- RefChem:150541
- MFCD28502028
- (R)-4-(3-Aminopyrrolidin-1-yl)-6-isopropylpyrimidin-2-amine
- UNII-5RV7T5BNMG
- SCHEMBL604514
- GTPL8984
- orb1309524
- GLXC-04851
- WRB44790
- BDBM50006789
- EX-A11126
- AKOS030628488
- EBC-521445
- T11723L
- JNJ 39758979 [WHO-DD]
- MS-23237
- HY-101189
- CS-0020957
- 4-[(3R)-3-Amino-1-pyrrolidinyl]-6-isopropyl-2-pyrimidinamine
- AKOS040733502
- orb1703326
- T24208
- HY-101189B
- W00RQD3LO2
- RefChem:201345
- JNJ-39758979 (dihydrochloride)
- JNJ-39758979 dihydrochloride
- CS-0120729
- UNII-W00RQD3LO2
- JNJ-39758979 2HCl
Look up JNJ-39758979 in the interactive SynDRA portal →